• video series 2016
  • resources 2016
  • AMS Congress 2016
  • memory 2016
  • info-sheets-2016
Menopause - what are the symptoms
Is Menopausal Hormone Therapy (HRT) safe?
Menopause - Non-hormonal Treatment Options

What's New?

  • Members update

    Cognitive functions, menopause and hormone therapy – an update; Sexual dysfunction in older women and metabolic syndrome;  Risk parameters for duration and peak severity of hot flushes; Changes Magazine; Eating disorders in midlif...
  • Menopause symptoms and relationship to demographic and psychosocial factors

    More data analysis about hot flushes from the Study of Women's Health Across the Nation (SWAN) has been published. The study by Ping G. Tepper, PhD, and colleagues shows that the progression of vasomotor symptoms (VMS) across the menopause transition...
  • Certain characteristics predispose women to different hot flush and night sweat patterns

    Most women will get hot flushes or night sweats at some point in life. However, when these symptoms occur and how long they last can vary dramatically among women. New findings show that women fit into four distinct groups when it comes to getting ho...
  • Memory and hormone therapy after menopause

    Contrary to popular belief, taking estrogen after menopause may not affect the memory and thinking abilities of healthy women no matter when the treatment is started. The study is among the first large, long-term clinical trial to examine the cogniti...
  • Cerebral Venous Sinus Thrombosis in Users of a Hormonal Vaginal Ring

    Oral contraceptive pills (OCPs) are a well-established precipitant of thrombosis. The local release of hormone from the vaginal ring still results in systemic administration and therefore predisposes users to increased risk of venous thrombosis. Alth...
  • Risk factors associated with the duration of hot flushes

    It appears that some features of hot flushes, a very common and disturbing symptom of menopause, are not yet fully understood and probably await further investigation. Full IMS Live comment here (members only - must login to view) Abstract Risk Fa...
  • Sorry folks, we were wrong at the time

    18 April 2016:  Despite the availability of effective hormonal and non-hormonal treatments for menopausal symptoms, few women with these symptoms are evaluated or treated   Whoever can download from The New England Journal of Medicin...

Features

  • Sexual difficulties in the menopause

    Key Points Sexual difficulties can be life-long or recently acquired, but they are a common presentation at menopause. Hormones are rarely the only factor involved in desire-arousal problems. Declining sexual function correlates with fal...
  • A model of care for healthy menopause and ageing: EMAS position statement

    Key points:  The conceptual framework of the Healthy Menopause and Ageing is a holistic model of care incorporating disease and disability. Healthcare model's core: lead clinician, specialist nurse, patient, interdisciplinary network of heal...
  • Are women suffering in silence? - UK survey

    New survey puts spotlight on significant impact of menopause despite recent guideline Findings presented at the British Menopause Society’s annual conference show only half of women surveyed in Great Britain (who are currently experiencing or who ha...
  • Early use of postmenopausal hormone therapy may prevent heart disease

    Findings suggest that after decades of research regarding the effectiveness of MHT on heart disease, timing may be everything:  Hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis, ...
  • Know your bones

    Bone fracture risk assessment:  An Australian-first bone health self-assessment tool designed to help consumers understand their bone fracture risk has been produced by Osteoporosis Australia and Garvan Institute of Medical Research. www.knowy...
  • Women with Low Libido: Who Not to Treat with Testosterone?

    Professor Davis explains how to best approach testosterone therapy for women.  Professor Susan Davis is an AMS Member and a leading women's health researcher. In 2005 she became the inaugural Chair of Women's Health in the Monash University ...
  • Progestins

    Not all progestins are the same:  A/Prof John Eden is a gynaecologist and reproductive endocrinologist. His research interests include managing menopause after breast cancer, polycystic ovarian syndrome, osteoporosis, hormone replacement ther...
cialis